New MRI-radiation hybrid machine in Alberta expected to improve cancer treatment by at least 20 per cent
Technology in Alberta that is expected to allow doctors to more accurately and effectively treat cancerous tumours with radiation enters clinical trials next week.
This next step, after 15 years of work, was celebrated in Edmonton on Friday as a "game changer" and "true medical breakthrough."
The LMR, or Linac-MR machine, simultaneously delivers radiotherapy and high-resolution imaging – something researchers say was previously considered impossible because the magnetic field and x-rays of the two machines interfere with each other if placed within 10 metres.
But a tumour's position can shift with a patient's movement, as they go between machines, or even by breathing. So doctors need to use radiation more conservatively to avoid hitting healthy tissue or organs near a tumour, which in turn means lower radiation doses and a higher number of treatment sessions.
"Say I know exactly where the tumour is without killing healthy tissue: We can calculate the cure rates will improve by 20 to 40 per cent for all solid tumours," creator Dr. Gino Fallone told reporters.
The medical physicist at the University of Alberta has been working on the idea with researchers from Edmonton's Cross Cancer Institute and Alberta Health Services since 2008.
Dr. Nawaid Usmani, who will lead the clinical study, also expects the machine will be able to treat tumours that are difficult to access – like prostate, liver, and pancreatic cancers.
"Over the course of your career, it's very rare to be involved in a true innovation, something that revolutionalizes how treatment is administered and is able to offer new treatments to patients," he commented during the news conference at the Cross Cancer Institute.
"I'm very fortunate to have been involved in this innovation as I've been able to witness right before my eyes this concept become a reality."
'VERY OPTIMISTIC'
Usmani's team is hoping to include 100 patients in the LMR's first year-long trial. Five more phases, each with roughly 100 more participants, will follow.
Marvin Bahry, an 84-year-old prostate cancer patient, will be the first-ever clinical trial participant.
Bahry first had prostate cancer around 12 years ago and told CTV News he has "high hopes" to beat it again.
"I'm very optimistic that all of his research and the hard work of Dr. Usmani and other doctors and nurses and so on, will benefit not only me but all the other people who come here," he said.
"Any good that comes out of it from me will benefit others and that's my little contribution to others in this world…I see nothing but good coming out of all of this."
Jordan Turko, a Cross Cancer Institute fundraiser and cancer survivor, echoed Bahry's thoughts: "When I think about innovations like this, it buys folks like me more time."
In April 2022, at 30 years old, he was diagnosed with Stage 4 lung cancer his doctor believes developed over a period of just four months. Nine months of targeted radiation and pill therapy later, he says his cancer has "fully retreated."
"For the average person, as time goes on, you get less of it. It goes on, you get a little older. But for cancer patients, it's ironic that within innovations like this, when we get a little more time," Turko said of the LMR.
"So things like this are a really big deal because they buy a little more time. Which hopefully means that another great innovator will buy more time and give us more moments in our life."
With files from CTV News Edmonton's Amanda Anderson
CTVNews.ca Top Stories
W5 Investigates | How did a healthy teen die at a minor hockey camp?
The parents of young Ontario hockey player Ben Teague have been searching for answers since he died while at a team retreat in 2019. The mystery about what happened and the code of silence in hockey culture is explored in CTV W5's 'What Happened to Ben,' on CTVNews.ca and W5's official YouTube channel.

China's Xi meeting Putin in boost for isolated Russia leader
Chinese leader Xi Jinping is due to meet with Vladimir Putin in a political boost for the isolated Russian president after the International Criminal Court charged him with war crimes in Ukraine.
Trump's call for protests gets muted reaction by supporters
Former U.S. President Donald Trump's calls for protests ahead of his anticipated indictment in New York have generated mostly muted reactions from supporters, with even some of his most ardent loyalists dismissing the idea as a waste of time or a law enforcement trap.
Woman suing Tim Hortons for $500K after hot tea spill left her 'disfigured'
An Ontario woman has launched a lawsuit seeking $500,000 from Tim Hortons after she suffered major burns from an alleged ‘superheated’ tea. The company has denied all allegations and said she was ‘the author of her own misfortune.'
LIVE @ 8 A.M. | Police give update on Old Montreal fire that left 1 dead, 6 missing
Police are giving an update on last week's fire in Old Montreal that killed at least one person and left six missing. Fire services began partially dismantling the building over the weekend, uncovering one body Sunday evening. Several units in the building were unauthorized short-term rentals, or Airbnbs.
Air passenger complaints triple in one year to pass 42,000 as backlog grows
The number of air passenger complaints to Canada's transport regulator is soaring, more than tripling to 42,000 over the past year.
Trails of human bacteria from sneezing and coughing preserved on Mount Everest: study
Even at one of the tallest natural peaks on Earth, humans have left their mark in a trail of bacteria as researchers have found germs from coughing and sneezing that have been potentially preserved for centuries on Mount Everest.
Credit Suisse, UBS shares plunge after takeover announcement
Shares of Credit Suisse plunged 63 per cent in early trading Monday after the announcement that banking giant UBS would buy its troubled rival for almost US$3.25 billion in a deal orchestrated by regulators to stave off further market-shaking turmoil in the global banking system.
Poilievre calling for national standardized test to license doctors, nurses trained outside of Canada
Conservative Leader Pierre Poilievre is calling for a national standardized testing process to be created in order to speed up the licensing process for doctors and nurses who are either immigrants or were trained abroad.